(This column is authored by Carol Koenigsknecht, Herbal Practitioner and owner of Terra Ken Herbals. She is available for consultations, classes and lectures, and can be reached via her website athttp://www.TerraKenHerbals.net or by phone, (706) 797-0091. She also owns and operates Carol’s Critter Care, a pet-sitting service.)
我故我在
2009年2月14日星期六
防治高血压的良好建议
腹型肥胖增加妇女偏头痛的风险
Belly Fat Linked to Risk of Migraines
WebMD Health News
Feb. 13, 2009 -- Belly fat has been linked to increased risks for heart disease and diabetes. Now new research suggests it may also be linked to an increased risk for migraines, at least until middle age.
Waist circumference was found to be a better predictor of migraine activity than general obesity in both men and women up until age 55.
Earlier research has linked obesity with an increase in the frequency of migraines in people who already have them. But the new study is one of the few to suggest that obesity raises the overall risk for migraines.
And it is the first to examine whether belly fat may play a specific role in migraines and severe frequent headaches.
The findings will be presented in April at the annual meeting of the American Academy of Neurology (AAN) in Seattle.
Belly Fat and Migraines
Researchers from Philadelphia's Drexel University College of Medicine examined data collected from more than 22,000 participants in the ongoing National Health and Nutrition Examination Survey (NHANES).
The survey included measurements of both abdominal obesity, measured by waist circumference, and overall obesity, as determined by body mass index (BMI). The data also include self-reported estimates of migraine and severe headache frequency.
Women are three times as likely as men to suffer from migraines. Researcher B. Lee Peterlin, DO, tells WebMD that the findings may help researchers understand this gender difference.
"This may be one piece of the puzzle," she says. "This does not suggest that if you lose your extra abdominal fat it will cure your migraines. But it may be a clue to help explain the sexual dimorphism in migraine."
Even after controlling for overall obesity, excess belly fat was associated with a significant increase in migraine activity in both men and women between the ages of 20 and 55.
"This is the age when migraine is most prevalent," she says. "Our findings suggest that both general obesity and abdominal obesity are associated with an increased prevalence of migraine in this age group."
Women with extra belly fat were 30% more likely to experience migraines than women without excess belly fat, even after accounting for overall obesity, risk factors for heart disease, and demographic characteristics. The link between belly fat and migraines in men in this age group was not significant when accounting for these factors.
Migraines in Women
The findings suggest that belly fat is an important risk factor for migraine, but it may be more important in women than in men, Peterlin says.
After age 55, carrying extra weight around the middle appeared to be associated with a slight decrease in migraine risk in women, but the reasons for this are not clear.
"That was a surprise," Peterlin says. "It appears that there is an impact at every age, but it changes. In women under 55, belly fat is bad. But over 55, having belly fat may actually be mildly protective against migraine."
Migraine researcher Stephen Silberstein, MD, tells WebMD that the new research raises more questions than it answers.
Silberstein is a spokesman for the American Academy of Neurology and a professor of neurology at Thomas Jefferson University in Philadelphia.
"The large population-based studies indicate that obesity correlates with the frequency, but not the presence of migraines," he says. "This is the first time anyone has looked at abdominal girth and they found that it predicts the presence of migraines. This is an interesting observation, but these findings would definitely need to be duplicated."
植物病毒提供智能炸弹炸死癌细胞
Washington, Feb 13 (ANI): In a major step towards better chemotherapy treatments, scientists have created tiny “smart bombs” by modifying a common plant virus, which can deliver drugs only to specific cells inside the human body without affecting surrounding tissue.
The researchers have revealed that each of these smart bombs is thousands of times smaller than the width of a human hair.
They say that the new approach may lead to more effective chemotherapy treatments with greatly reduced, or even eliminated, side effects.
In a collaborative effort, Drs. Stefan Franzen, professor of chemistry, and Steven Lommel, professor of plant pathology and genetics, used the special properties of a fairly common and non-toxic plant virus as a means to convey drugs to the target cells.
According to the researchers, the virus is appealing in both its ability to survive outside of a plant host and its built-in “cargo space” of 17 nano-meters, which can be used to carry chemotherapy drugs directly to tumour cells.
They deployed the virus by attaching small proteins, called signal peptides, to its exterior that cause the virus to “seek out” particular cells, such as cancer cells.
The same signal peptides serve as “passwords” that allow the virus to enter the cancer cell, where it releases its cargo.
“We had tried a number of different nanoparticles as cell-targeting vectorsThe plant virus is superior in terms of stability, ease of manufacture, ability to target cells and ability to carry therapeutic cargo,” said Franzen.
Calcium is the key to keeping the virus” cargo enclosed. When the virus is in the bloodstream, calcium is also abundant.
However, inside individual cells, calcium levels are much lower, which allows the virus to open, delivering the cancer drugs only to the targeted cells.
“Another factor that makes the virus unique is the toughness of its shell. When the virus is in a closed state, nothing will leak out of the interior, and when it does open, it opens slowly, which means that the virus has time to enter the cell nucleus before deploying its cargo, which increases the drug’’s efficacy,” said Lommel.
The researchers are hoping that their method will alleviate the side effects of common chemotherapy treatments, while maximizing the effectiveness of the treatment